News
Under the terms of the partnership, Abbott will utilise its distribution infrastructure to promote MSD’s sitagliptin-based ...
Abbott and MSD announce partnership to distribute sitagliptin brands in India, aiming to strengthen reach in ₹950-1,000 crore ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results